In-house IP roundup: Charities seek better IP deals; medical device start-ups' patent catch-22; USPTO eligibility guidance creates consistency

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house IP roundup: Charities seek better IP deals; medical device start-ups' patent catch-22; USPTO eligibility guidance creates consistency

Flying money

Managing IP rounds up the latest news and analysis from patent-focused businesses

Piggy

Donation drop pushes medical funders to seek better IP deals

Healthcare charity IP managers say they are negotiating fairer patent commercialisation and management arrangements with universities to replace falling revenue streams and generate cash for new projects. Read more ...




MoneyMedical device start-ups face patent investment catch-22

Fledgling businesses in the medical device sector must spend enormous sums of money developing and protecting their inventions to penetrate the market and attract investment. But they often only have enough start-up money for one of those needs. Read more ...





image1USPTO eligibility guidance could create consistency for tech and life sciences

Barclays, Regeneron, Amadeus and others say the new guidance on Section 101-related subject matter could lead to more reliable patent examinations – and may mark the start of a post-Alice framework reversal. Read more ...







Sign up
 to receive more content like this in Patent Strategy’s weekly newsletter.





more from across site and SHARED ros bottom lb

More from across our site

AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has seemingly committed to hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
With the London Annual Meeting behind us, we look back at some of the lessons learned this week and ahead to what 2027 will bring
In-house counsel aren’t impressed with law firms’ international networks, but practitioners say they are crucial for business
Gift this article